Liquid biopsy in bladder cancer: State of the art and future perspectives

被引:71
作者
Crocetto, Felice [1 ]
Barone, Biagio [1 ]
Ferro, Matteo [2 ]
Busetto, Gian Maria [3 ]
La Civita, Evelina [4 ]
Buonerba, Carlo [5 ]
Di Lorenzo, Giuseppe [5 ,7 ]
Terracciano, Daniela [4 ]
Schalken, Jack A. [6 ]
机构
[1] Univ Naples Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Naples, Italy
[2] IEO European Inst Oncol IRCCS, Dept Urol, Milan, Italy
[3] Univ Foggia, Dept Med & Surg Sci, Urol & Renal Transplantat Unit, Foggia, Italy
[4] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy
[5] Hosp Andrea Tortora, Oncol Unit, ASL Salerno, Pagani, Italy
[6] Radboud Univ Nijmegen, Dept Urol, Med Ctr, Nijmegen, Netherlands
[7] Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy
关键词
Urinary biomarker; Bladder cancer; Liquid biopsy; Cytology; URINE CYTOLOGY; FOLLOW-UP; CYFRA; 21-1; CYTOKERATIN-19; FRAGMENT; UROTHELIAL CARCINOMA; DIAGNOSTIC-ACCURACY; IMMUNOCYT TEST; RAPID TEST; SURVEILLANCE; MUTATIONS;
D O I
10.1016/j.critrevonc.2022.103577
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bladder cancer is the most common malignancy of the urinary tract. Cystoscopy represents the gold standard in the diagnosis of suspicious bladder lesions. However, the procedure is invasive and burdened by pain, discomfort and infective complications. Cytology, which represents an alternative diagnostic possibility is limited by poor sensitivity. Considering the limitations of both procedures, and the necessity to perform multiple evaluations in patients who are in follow-up for bladder cancer, an improved non-invasive methodology is required in the clinical management of this disease. Liquid biopsy, e.g. the detection of clinical biomarkers in urine, represent a promising novel and non-invasive approach that could overcome those limitations and be integrated into the current clinical practice. The aim of this review is to summarize the state of the art of this approach and the latest novelties regarding detection, prognosis and surveillance of bladder cancer.
引用
收藏
页数:9
相关论文
共 111 条
[1]   Assessing the Clinical Benefit of UBC Rapid in the Surveillance and Initial Diagnosis of Bladder Cancer [J].
Agreda Castaneda, Fernando ;
Raventos Busquets, Carles Xavier ;
Morote Robles, Juan .
CLINICAL GENITOURINARY CANCER, 2020, 18 (03) :230-235
[2]   Histologic Variants of Urothelial Carcinoma: Morphology, Molecular Features and Clinical Implications [J].
Alderson, Meera ;
Grivas, Petros ;
Milowsky, Matthew I. ;
Wobker, Sara E. .
BLADDER CANCER, 2020, 6 (02) :107-122
[3]   Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study [J].
Anastasi, Emanuela ;
Maggi, Martina ;
Tartaglione, Sara ;
Angeloni, Antonio ;
Gennarini, Giuseppina ;
Leoncini, Pier Paolo ;
Sperduti, Isabella ;
Di Lascio, Giovanni ;
De Stefano, Virgilio ;
Di Pierro, Giovanni Battista ;
Del Giudice, Francesco ;
Busetto, Gian Maria ;
De Berardinis, Ettore ;
Sciarra, Alessandro .
DIAGNOSTIC CYTOPATHOLOGY, 2020, 48 (11) :1034-1040
[4]   Serum CYFRA 21-1 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy [J].
Andreadis, C ;
Touloupidis, S ;
Galaktidou, G ;
Kortsaris, AH ;
Boutis, A ;
Mouratidou, D .
JOURNAL OF UROLOGY, 2005, 174 (05) :1771-1775
[5]   Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer [J].
Avogbe, Patrice Hodonou ;
Manel, Arnaud ;
Vian, Emmanuel ;
Durand, Geoffroy ;
Forey, Nathalie ;
Voegele, Catherine ;
Zvereva, Maria ;
Hosen, Wi Ismail ;
Meziani, Sonia ;
De Tilly, Berengere ;
Polo, Gilles ;
Lole, Olesia ;
Francois, Pauline ;
Delhomme, Tiffany Myriam ;
Carreira, Christine ;
Monteiro-Reis, Sara ;
Henrique, Rui ;
Abedi-Ardekani, Behnoush ;
Byrnes, Graham ;
Foll, Matthieu ;
Weiderpass, Elisabete ;
McKay, James ;
Jeronimo, Carmen ;
Scelo, Ghislaine ;
Le Calvez-Kelm, Florence .
EBIOMEDICINE, 2019, 44 :431-438
[6]  
Babbra RK, 2020, INT J RADIAT ONCOL, V108, pE916
[7]   Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma [J].
Babjuk, M. ;
Soukup, V. ;
Pesl, M. ;
Kostirova, M. ;
Drncova, E. ;
Smolova, H. ;
Szakacsova, M. ;
Getzenberg, R. ;
Pavlik, I. ;
Dvoracek, J. .
UROLOGY, 2008, 71 (04) :718-722
[8]   Non-invasive Detection of Bladder Cancer by UBC Rapid Test, Ultrasonography and Cytology [J].
Barak, Vivian ;
Itzkovich, Dror ;
Einarsson, Roland ;
Gofrit, Ofer ;
Pode, Dov .
ANTICANCER RESEARCH, 2020, 40 (07) :3967-3972
[9]   Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study [J].
Batista, Rui ;
Vinagre, Joao ;
Prazeres, Hugo ;
Sampaio, Cristina ;
Peralta, Pedro ;
Conceicao, Paulo ;
Sismeiro, Amlcar ;
Leao, Ricardo ;
Gomes, Andreia ;
Furriel, Frederico ;
Oliveira, Carlos ;
Torres, Joao Nuno ;
Eufrasio, Pedro ;
Azinhais, Paulo ;
Almeida, Fabio ;
Romero Gonzalez, Edwin ;
Bidovanets, Bohdan ;
Ecke, Thorsten ;
Stinjs, Pascal ;
Serrano Pascual, Alvaro ;
Abdelmalek, Rabehi ;
Villafruela, Ainara ;
Beardo-Villar, Pastora ;
Fidalgo, Nuno ;
Ozturk, Hakan ;
Gonzalez-Enguita, Carmen ;
Monzo, Juan ;
Lopes, Tome ;
Alvarez-Maestro, Mario ;
Parra Servan, Patricia ;
Perez De La Cruz, Santiago Moreno ;
Sanchez Perez, Mario Pual ;
Maximo, Valdemar ;
Soares, Paula .
FRONTIERS IN GENETICS, 2019, 10
[10]   FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study [J].
Beukers, Willemien ;
van der Keur, Kirstin A. ;
Kandimalla, Raju ;
Vergouwe, Yvonne ;
Steyerberg, Ewout W. ;
Boormans, Joost L. ;
Jensen, Jorgen B. ;
Lorente, Jose A. ;
Real, Francisco X. ;
Segersten, Ulrike ;
Orntoft, Torben F. ;
Malats, Nuria ;
Malmstrom, Per-Uno ;
Dyrskjot, Lars ;
Zwarthoff, Ellen C. .
JOURNAL OF UROLOGY, 2017, 197 (06) :1410-1417